
No. of Pages: 138 | Report Code: TIPRE00003908 | Category: Life Sciences
No. of Pages: 138 | Report Code: TIPRE00003908 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Genome Editing Market– By Technology
1.3.2 Europe Genome Editing Market– By Application
1.3.3 Europe Genome Editing Market– By End User
1.3.4 Europe Genome Editing Market– By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5.1 Market Drivers
5.1.1 Burgeoning Prevalence of Cancer and Other Genetic Disorders
5.1.2 Progressive Technological Advancements in Gene-Editing Tools
5.2 Market Restraints
5.2.1 Expensive Cost of Genomic Equipment
5.3 Future Trends
5.3.1 Growing Technological Innovations
5.4 Impact Analysis
6.1 Europe Genome Editing Market Revenue Forecast and Analysis
7.1 Overview
7.2 Europe Genome Editing Market, By Technology, 2021 & 2028 (%)
7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7.3.1 Overview
7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.4 TALEN
7.4.1 Overview
7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.5 Antisense
7.5.1 Overview
7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.1 Overview
8.2 Europe Genome Editing Market Share, By Application - 2021 & 2028 (%)
8.3 Cell Line Engineering
8.3.1 Overview
8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genetic Engineering
8.4.1 Overview
8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Applications
8.5.1 Overview
8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Discovery
8.6.1 Overview
8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.1 Overview
9.2 Europe Genome Editing Market Share by End User - 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinical Research Organizations (CRO’s)
9.4.1 Overview
9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.1 Overview
10.1.1 Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4 Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14.1 Glossary of Terms
Table 1. Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 4. France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 6. France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, Europe Genome Editing Market
Figure 1. Europe Genome Editing Market Segmentation
Figure 2. Europe Genome Editing Market Segmentation, By Country
Figure 3. Europe Genome Editing Market Overview
Figure 4. CRISPR Held Largest Share of Technology Segment in Europe Genome Editing Market
Figure 5. Germany to Show Remarkable Growth During Forecast Period
Figure 6. Europe Genome Editing Market, Industry Landscape
Figure 7. Europe: PEST Analysis
Figure 8. Expert Opinion
Figure 9. Europe Genome Editing Market Impact Analysis of Drivers and Restraints
Figure 10. Europe Genome Editing Market– Revenue Forecast and Analysis – 2021-2028
Figure 11. Europe Genome Editing Market, by Technology, 2021 & 2028 (%)
Figure 12. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Genome Editing Market Share, by Application - 2021 & 2028 (%)
Figure 17. Cell Line Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Genetic Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Diagnostic Applications: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Drug Discovery: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Others: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Europe Genome Editing Market Share by End User - 2021 & 2028 (%)
Figure 23. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Europe: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 28. Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Impact of COVID-19 Pandemic in European Country Markets